Healthcare
Live Price
Offline$4.29
-9.68% today
Window Change
-36.67%
Window
Dec 4, 2025 → Jun 17, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 133 bars · Dec 4, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regentis Biomaterials Ltd. (RGNT) is a Healthcare stock with a market cap of $10.00M and listed on AMEX. The stock last traded around $4.29 and down 36.7% across the available one-year price window (Dec 4, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines RGNT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGNT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGNT Max Drawdown
-83.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGNT and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for RGNT
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.